The Biodistribution of [18F]-Clofarabine in Cancer Patients Before and After Interventions That Increase the Activity of Deoxycytidine Kinase
Phase of Trial: Phase II
Latest Information Update: 18 Sep 2017
At a glance
- Drugs Clofarabine (Primary)
- Indications Cancer
- Focus Pharmacokinetics
- 12 Sep 2017 Planned End Date changed from 1 Dec 2021 to 12 Jun 2021.
- 12 Sep 2017 Planned primary completion date changed from 1 Dec 2020 to 12 Jun 2020.
- 21 Sep 2016 New trial record